GLP-1 medications target the signaling pathways that regulate hunger, satiety, and how your body stores fat, giving you a biological advantage that diet and exercise alone can't replicate
Overall, tirzepatide and semaglutide share a very similar side effect profile, particularly for digestive issues like nausea, diarrhea, abdominal pain, and dyspepsia
This, coupled with the fact that more people are likely to be interested in a pill rather than a shot, is giving employers pause
What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have
This approach not only reduces pain but also boosts your overall health
When paired with Medicubes BoosterH or BoosterPro device, results are amplified glow improves by 9.9%, wrinkles soften by up to 11%, and pigmentation fades deeper